Phytic acid attenuates inflammatory responses and the levels of NF-κB and p-ERK in MPTP-induced Parkinson's disease model of mice

Neurosci Lett. 2015 Jun 15:597:132-6. doi: 10.1016/j.neulet.2015.04.040. Epub 2015 Apr 27.

Abstract

Phytic acid (PA) is a naturally occurring constituent which exhibits protective action in Parkinson's disease (PD). Inflammation in the central nervous system (CNS) is strongly associated with neuronal death in PD. However, the molecular mechanism of the protective effect of PA in PD has not been fully elucidated. In this study, we tried to testify the protection of PA on neuron and inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD model of mice and investigated the mechanism involved in them. Motor behavior test and tyrosine hydroxylase (TH) immunohistochemistry method showed PA significantly inhibited MPTP-induced dopaminergic cell loss in the substantia nigra (SN). Moreover, using immunohistochemistry method and quantitative polymerase chain reaction (qPCR), microglial activation and inducible nitric oxide synthase (iNOS) were found to be markedly repressed by PA. Via western blot assay, expressions of nuclear factor κB (NF-κB) and phosphorylated extracellular signal-regulated kinase (p-ERK) were significantly attenuated by PA. In conclusion, it is suggested that PA has a neuroprotective effect in MPTP-induced PD model and the neuroprotection is correlated with its anti-inflammatory effect which may be associated with suppression of pathways that involved in NF-κB and p-ERK.

Keywords: ERK; Inflammation; NF-κB; Parkinson’s disease; Phytic acid; iNOS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Anti-Inflammatory Agents / therapeutic use
  • Calcium-Binding Proteins / metabolism
  • Dopaminergic Neurons / pathology
  • Enzyme Activation
  • Inflammation / drug therapy
  • Inflammation / metabolism
  • Male
  • Mice, Inbred C57BL
  • Microfilament Proteins / metabolism
  • Microglia / metabolism
  • Mitogen-Activated Protein Kinase 1 / metabolism*
  • Mitogen-Activated Protein Kinase 3 / metabolism*
  • Motor Skills / drug effects
  • NF-kappa B / metabolism*
  • Neuroprotective Agents / pharmacology*
  • Neuroprotective Agents / therapeutic use
  • Nitric Oxide Synthase Type II / metabolism
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / metabolism
  • Parkinson Disease / physiopathology
  • Pars Compacta / drug effects
  • Pars Compacta / pathology
  • Phosphorylation
  • Phytic Acid / pharmacology*
  • Phytic Acid / therapeutic use

Substances

  • Aif1 protein, mouse
  • Anti-Inflammatory Agents
  • Calcium-Binding Proteins
  • Microfilament Proteins
  • NF-kappa B
  • Neuroprotective Agents
  • Phytic Acid
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Nitric Oxide Synthase Type II
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3